Thomas Geiger

5.9k citations
70 papers · 4.6k indexed · 1 hit paper · h-index 26

Thomas Geiger

69 papers receiving 4.4k citations

Hit Papers

Interleukin‐6 is the major regulator of acute phase prote...7451989202620012013200400600

Peers

Thomas Geiger
Comparison fields: 5 of 128
  • Immunology 1.3k
  • Oncology 986
  • Hepatology 224
  • Molecular Biology 1.8k
  • Cancer Research 337
Replace Ichiro Sekine with:
Ichiro Sekine Japan
H Baumann United States
Karel Geboes Belgium
Atsushi Muraguchi Japan
Alejandro Zentella‐Dehesa Mexico
Satoshi Ito Japan
Frederick C. de Beer United States
Tonino Alonzi Italy
Susan Acton United States
Akio Morinobu Japan
Thomas Geiger relative to Ichiro Sekine Japan Ichiro Sekine's profile →
Citations per field
00.5×2.7×
Ichiro Sekine · 1×
Citations per year

Countries citing papers authored by Thomas Geiger

Since Specialization
Citations

This map shows the geographic impact of Thomas Geiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Geiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Geiger more than expected).

Fields of papers citing papers by Thomas Geiger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Geiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Geiger. The network helps show where Thomas Geiger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Geiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Geiger Line = papers co-authored together Thomas Geiger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202512
2 20253
3 20250
4 20239
5 20231
6 20232
7 202312
8 201913
9 201938
10 201913
11 20188
12
Automated Extraction of Semantic Information from German Legal Documents
20174
13 1993424
14 199236
15
An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugs.
198925
16 198959
17 1988225
18 198820
19 1988170
20 19815

About Thomas Geiger

Thomas Geiger is a scholar working on Immunology, Molecular Biology, Immunology and Allergy, Oncology and Cancer Research, having authored 70 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (12 papers), Signaling Pathways in Disease (11 papers), Protein Degradation and Inhibitors (10 papers), Protein purification and stability (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), DNA and Nucleic Acid Chemistry (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (986 citations), Hepatology (224 citations), Molecular Biology (1.8k citations) and Cancer Research (337 citations). Thomas Geiger has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Peter C. Heinrich, Tilo Andus, Toshio Hirano, José V. Castell, Doriano Fabbro, Brett P. Monia, Marcel A. Müller, C H Heusser, Volker Brinkmann and Ş. Ş. Alkan. Their work appears in journals such as European Journal of Biochemistry, Inflammation Research, FEBS Letters, Angewandte Chemie International Edition and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026